Literature DB >> 7688713

Soluble CD59 in pregnancy and infancy.

L Bjørge, T S Jensen, C A Vedeler, E Ulvestad, E K Kristoffersen, R Matre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7688713     DOI： 10.1016/0165-2478(93)90058-a

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  7 in total

1.  Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.

Authors:  L I Brasoveanu; E Fonsatti; A Visintin; M Pavlovic; I Cattarossi; F Colizzi; A Gasparollo; S Coral; V Horejsi; M Altomonte; M Maio
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

3.  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Authors:  S Meri; T Lehto; C W Sutton; J Tyynelä; M Baumann
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

4.  Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.

Authors:  J Hakulinen; S Meri
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).

Authors:  G A Niehans; D L Cherwitz; N A Staley; D J Knapp; A P Dalmasso
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

6.  The expression of CD59 in normal human nervous tissue.

Authors:  C Vedeler; E Ulvestad; L Bjørge; G Conti; K Williams; S Mørk; R Matre
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

7.  Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.

Authors:  Kevin Budding; Eduard A van de Graaf; Tineke Kardol-Hoefnagel; Johanna M Kwakkel-van Erp; Bart D Luijk; Erik-Jan D Oudijk; Diana A van Kessel; Jan C Grutters; C Erik Hack; Henderikus G Otten
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.